The Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria – Trademark Portfolio
Entity Type: 03
The Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 3 Nice Classification classes. The owner is based in New York, NY.
36th Floor
New York, NY 10006
Showing of trademarks Trademarks
Trademark Classifications
The Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does The Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria have?
The Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria has 2 U.S. trademarks filed with the USPTO.
What trademark classes does The Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria file in?
The Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 41 (Education & Entertainment), Class 16 (Paper Goods). Class 35 covers advertising; business management; business administration; office functions.
What is The Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria's trademark registration success rate?
The Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria has a 0% trademark registration rate, with 0 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.